drugset / Trial / NCT02853136
Influence of Fluvoxamine on the Pharmacokinetics of BI 409306
RandomizedCrossoverOpen-labelTreatment
Summary
To investigate the influence of fluvoxamine on the pharmacokinetics of BI 409306
Timeline
- Start
- 2016-08-25
- Primary completion
- 2016-10-17
- Completion
- 2016-10-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluvoxamine | Unknown | 100 mg | Oral |
| Subject | OSORESNONTRINE | Small molecule | 3 mg | Oral |
| Subject | OSORESNONTRINE | Small molecule | 10 mg | Oral |
Indications
No indication recorded.